ATE42750T1 - Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE42750T1
ATE42750T1 AT85402528T AT85402528T ATE42750T1 AT E42750 T1 ATE42750 T1 AT E42750T1 AT 85402528 T AT85402528 T AT 85402528T AT 85402528 T AT85402528 T AT 85402528T AT E42750 T1 ATE42750 T1 AT E42750T1
Authority
AT
Austria
Prior art keywords
group
tetrapeptides
gastric
elimination
tri
Prior art date
Application number
AT85402528T
Other languages
English (en)
Inventor
Jean Martinez
Jean Pierre Bali
Richard Magous
Bertrand Castro
Henri Demarne
Original Assignee
Sanofi Sa
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Centre Nat Rech Scient filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE42750T1 publication Critical patent/ATE42750T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT85402528T 1984-12-20 1985-12-18 Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE42750T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8419545A FR2575164B1 (fr) 1984-12-20 1984-12-20 Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
EP85402528A EP0187095B1 (de) 1984-12-20 1985-12-18 Ester von Tri- und Tetrapeptiden, Hemmungsstoff gastrischer Ausscheidung, Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE42750T1 true ATE42750T1 (de) 1989-05-15

Family

ID=9310829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85402528T ATE42750T1 (de) 1984-12-20 1985-12-18 Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (7)

Country Link
US (1) US4687759A (de)
EP (1) EP0187095B1 (de)
JP (1) JPS61197595A (de)
AT (1) ATE42750T1 (de)
CA (1) CA1275550C (de)
DE (1) DE3569930D1 (de)
FR (1) FR2575164B1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023077A (en) * 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
EP0380230B1 (de) * 1989-01-24 1994-11-17 Aphton Corporation Immunogenische Zusammensetzungen gegen Gastrin-Peptide
US6861510B1 (en) 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
PT1077721E (pt) * 1998-05-15 2007-06-21 Receptor Biologix Inc Prevenção e tratamento da hipergastrinemia.
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
CA2441228A1 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
KR20040049830A (ko) * 2001-07-09 2004-06-12 애프톤 코포레이션 간, 폐 및 식도의 암 및 전암 상태의 치료 및 예방
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
CN1781023A (zh) * 2003-03-28 2006-05-31 埃弗顿有限公司 胃泌素激素免疫测定
AU2005228897B2 (en) * 2004-03-29 2009-12-10 Cancer Advances, Inc. Monoclonal antibodies to gastrin hormone
JP2008513536A (ja) 2004-09-22 2008-05-01 レセプター バイオロジックス インコーポレイテッド プロガストリンに対するモノクローナル抗体
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042487A (en) * 1964-06-25 1966-09-14 Ici Ltd Polypeptide derivatives
US3875137A (en) * 1973-04-20 1975-04-01 Searle & Co N-Substituted aspactyl peptide amids
US4012367A (en) * 1976-02-05 1977-03-15 G. D. Searle & Co. Anti-ulcer polypeptides containing L-aspartic acid and intermediates thereto
HU175152B (hu) * 1976-12-30 1980-05-28 Richter Gedeon Vegyeszet Sposob poluchenija peptidov s gastrin-aktivnost'ju, soderzhahhikh amino-oksi-kisloty
FR2537971A1 (fr) * 1982-12-16 1984-06-22 Commissariat Energie Atomique Nouveaux derives peptidiques, leur procede de fabrication et leur utilisation pharmaceutique

Also Published As

Publication number Publication date
FR2575164B1 (fr) 1987-03-20
JPS61197595A (ja) 1986-09-01
FR2575164A1 (fr) 1986-06-27
EP0187095B1 (de) 1989-05-03
CA1275550C (en) 1990-10-23
US4687759A (en) 1987-08-18
EP0187095A1 (de) 1986-07-09
DE3569930D1 (en) 1989-06-08

Similar Documents

Publication Publication Date Title
ATE42750T1 (de) Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3484691D1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IL67965A0 (en) Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt thereof,certain compounds derived from 3-hydroxybutanoic acid and their preparation
AU541747B2 (en) N-(vinblastinoyl-23)derivatives of amino acid and peptides
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
DE3875538D1 (de) Aminoluciferine, verfahren zu deren herstellung und ihre verwendung.
KR900006363A (ko) 신규한 펩티다제 억제제
DK444582A (da) Fremgangsmaade til fremstilling af peptider
ES8406438A1 (es) Procedimiento para preparar nuevos derivados de aminoacidos triciclicos
DE3264693D1 (en) Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use
CA2060034A1 (en) Tumour growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
BR0312889A (pt) Polipeptìdeo t20 peguilado
HU896606D0 (en) Process for the preparation of aminoacid derivatives inhibiting enzymes and pharmaceutical compositions thereof
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
ATE45165T1 (de) Reduzierte peptide, hemmungsstoffe gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DK137085D0 (da) Fremgangsmaade og mellemprodukter til fremstilling af racematfattigepeptider
JPS6393796A (ja) ペプチド合成の脱保護基用薬剤
Chassaing et al. Transformation of methionine into S-tert-butylhomocysteine. Application to a methionine-containing peptide: Substance P
AU1779088A (en) Guanidine-related compounds comprising a tetraphenylborate ion, process for obtaining these compounds and use of the compounds in peptide synthesis
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
DE3650564D1 (de) Dipeptide-Analoge von Aspertam und Verfahren zur deren Herstellung, sowie eine neue Herstellung von Aspertam
DE69324019D1 (de) Pyridinyl/quinolinyl-endgruppen enthaltende alkylamino-ethynyl-alanin-amindiol derivate zur behandlung von bluthochdruck
DE4445939A1 (de) Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen (II)
IT1270613B (it) Lattami biciclici come intermedi per la sintesi di peptidi biologicamente attivi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee